Browsing: Caris Life sciences
In this week’s edition of InnovationRx, we look at efforts to improve prior authorization, commercializing Bell Labs’ IP portfolio, a…
The successful IPO of Caris Life Sciences makes its founder David Dean Halbert worth an estimated $3.3 billion. David Dean…